These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 22854402

  • 1. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
    Alvarez JA, Law J, Coakley KE, Zughaier SM, Hao L, Shahid Salles K, Wasse H, Gutiérrez OM, Ziegler TR, Tangpricha V.
    Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial.
    Sadiya A, Ahmed SM, Carlsson M, Tesfa Y, George M, Ali SH, Siddieg HH, Abusnana S.
    Eur J Clin Nutr; 2015 Jun; 69(6):707-11. PubMed ID: 25406966
    [Abstract] [Full Text] [Related]

  • 4. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
    Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W, Someren JT, Tangpricha V.
    Endocr Pract; 2008 Jun; 14(1):10-7. PubMed ID: 18238736
    [Abstract] [Full Text] [Related]

  • 5. The Effect of Vitamin D Supplementation on Bone Metabolic Markers in Chronic Kidney Disease.
    Yadav AK, Kumar V, Kumar V, Banerjee D, Gupta KL, Jha V.
    J Bone Miner Res; 2018 Mar; 33(3):404-409. PubMed ID: 29044707
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit.
    Premaor MO, Scalco R, da Silva MJ, Froehlich PE, Furlanetto TW.
    J Bone Miner Metab; 2008 Mar; 26(6):603-8. PubMed ID: 18979160
    [Abstract] [Full Text] [Related]

  • 8. High-dose vitamin D3 reduces circulating hepcidin concentrations: A pilot, randomized, double-blind, placebo-controlled trial in healthy adults.
    Smith EM, Alvarez JA, Kearns MD, Hao L, Sloan JH, Konrad RJ, Ziegler TR, Zughaier SM, Tangpricha V.
    Clin Nutr; 2017 Aug; 36(4):980-985. PubMed ID: 27402475
    [Abstract] [Full Text] [Related]

  • 9. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.
    Samaan F, Carvalho AB, Pillar R, Rocha LA, Cassiolato JL, Cuppari L, Canziani MEF.
    J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial.
    Tukvadze N, Sanikidze E, Kipiani M, Hebbar G, Easley KA, Shenvi N, Kempker RR, Frediani JK, Mirtskhulava V, Alvarez JA, Lomtadze N, Vashakidze L, Hao L, Del Rio C, Tangpricha V, Blumberg HM, Ziegler TR.
    Am J Clin Nutr; 2015 Nov; 102(5):1059-69. PubMed ID: 26399865
    [Abstract] [Full Text] [Related]

  • 12. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
    Strugnell SA, Sprague SM, Ashfaq A, Petkovich M, Bishop CW.
    Am J Nephrol; 2019 Nov; 49(4):284-293. PubMed ID: 30878999
    [Abstract] [Full Text] [Related]

  • 13. Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.
    Kendrick J, Andrews E, You Z, Moreau K, Nowak KL, Farmer-Bailey H, Seals DR, Chonchol M.
    Clin J Am Soc Nephrol; 2017 Sep 07; 12(9):1438-1446. PubMed ID: 28784657
    [Abstract] [Full Text] [Related]

  • 14. Cholecalciferol Additively Reduces Serum Parathyroid Hormone and Increases Vitamin D and Cathelicidin Levels in Paricalcitol-Treated Secondary Hyperparathyroid Hemodialysis Patients.
    Zheng JQ, Hou YC, Zheng CM, Lu CL, Liu WC, Wu CC, Huang MT, Lin YF, Lu KC.
    Nutrients; 2016 Nov 05; 8(11):. PubMed ID: 27827962
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease.
    Hari P, Gupta N, Hari S, Gulati A, Mahajan P, Bagga A.
    Pediatr Nephrol; 2010 Dec 05; 25(12):2483-8. PubMed ID: 20872152
    [Abstract] [Full Text] [Related]

  • 16. [Cholecalciferol supplementation improves secondary hyperparathyroidism control in hemodialysis patients].
    Massimetti C, Bellasi A, Feriozzi S.
    G Ital Nefrol; 2020 Jun 10; 37(3):. PubMed ID: 32530156
    [Abstract] [Full Text] [Related]

  • 17. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.
    Ramirez-Sandoval JC, Arvizu-Hernandez M, Cruz C, Vazquez-Cantu B, Rojas-Concha LJ, Tamez L, Reynerio F, Gomez FE, Correa-Rotter R.
    J Nephrol; 2019 Aug 10; 32(4):645-659. PubMed ID: 30888584
    [Abstract] [Full Text] [Related]

  • 18. Effect of cholecalciferol on parathyroid hormone and vitamin D levels in chronic kidney disease.
    Basturk T, Unsal A, Ulas T.
    Minerva Urol Nefrol; 2011 Dec 10; 63(4):287-92. PubMed ID: 21996984
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis.
    Wasse H, Huang R, Long Q, Singapuri S, Raggi P, Tangpricha V.
    Am J Clin Nutr; 2012 Feb 10; 95(2):522-8. PubMed ID: 22237061
    [Abstract] [Full Text] [Related]

  • 20. Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.
    Stubbs JR, Zhang S, Friedman PA, Nolin TD.
    Clin J Am Soc Nephrol; 2014 Nov 07; 9(11):1965-73. PubMed ID: 25183657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.